Berkhout TA[au] - Search Results

Year	Number of Results
1979	1
1984	3
1985	2
1986	1
1987	1
1990	1
1991	1
1995	1
1996	1
1997	3
1998	1
2000	3
2003	2
2004	1
2022	0

1

Analysis of histones from the yeast Saccharomyces carlsbergensis.

Pastink A, Berkhout TA, Mager WH, Planta RJ. Pastink A, et al. Among authors: berkhout ta. Biochem J. 1979 Mar 1;177(3):917-23. doi: 10.1042/bj1770917. Biochem J. 1979. PMID: 220954 Free PMC article.

2

CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach.

Berkhout TA, Blaney FE, Bridges AM, Cooper DG, Forbes IT, Gribble AD, Groot PH, Hardy A, Ife RJ, Kaur R, Moores KE, Shillito H, Willetts J, Witherington J. Berkhout TA, et al. J Med Chem. 2003 Sep 11;46(19):4070-86. doi: 10.1021/jm030862l. J Med Chem. 2003. PMID: 12954060

3

Induction of cytochrome P4503A by the antiglucocorticoid mifepristone and a novel hypocholesterolaemic drug.

Williams JA, Chenery RJ, Berkhout TA, Hawksworth GM. Williams JA, et al. Among authors: berkhout ta. Drug Metab Dispos. 1997 Jun;25(6):757-61. Drug Metab Dispos. 1997. PMID: 9193879

4

The role of fractalkine in the recruitment of monocytes to the endothelium.

Chapman GA, Moores KE, Gohil J, Berkhout TA, Patel L, Green P, Macphee CH, Stewart BR. Chapman GA, et al. Among authors: berkhout ta. Eur J Pharmacol. 2000 Mar 31;392(3):189-95. doi: 10.1016/s0014-2999(00)00117-5. Eur J Pharmacol. 2000. PMID: 10762673

5

SR-12813 lowers plasma cholesterol in beagle dogs by decreasing cholesterol biosynthesis.

Berkhout TA, Simon HM, Jackson B, Yates J, Pearce N, Groot PH, Bentzen C, Niesor E, Kerns WD, Suckling KE. Berkhout TA, et al. Atherosclerosis. 1997 Sep;133(2):203-12. doi: 10.1016/s0021-9150(97)00131-7. Atherosclerosis. 1997. PMID: 9298680

6

The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.

Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, Kallen KJ, Rose-John S, Ludwig A. Hundhausen C, et al. Among authors: berkhout ta. Blood. 2003 Aug 15;102(4):1186-95. doi: 10.1182/blood-2002-12-3775. Epub 2003 Apr 24. Blood. 2003. PMID: 12714508 Free article.

7

The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.

Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S, Muetze B, Schuster B, Kallen KJ, Saftig P, Rose-John S, Ludwig A. Abel S, et al. Among authors: berkhout ta. J Immunol. 2004 May 15;172(10):6362-72. doi: 10.4049/jimmunol.172.10.6362. J Immunol. 2004. PMID: 15128827 Free article.

8

The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

Berkhout TA, Simon HM, Patel DD, Bentzen C, Niesor E, Jackson B, Suckling KE. Berkhout TA, et al. J Biol Chem. 1996 Jun 14;271(24):14376-82. doi: 10.1074/jbc.271.24.14376. J Biol Chem. 1996. PMID: 8662919 Free article.

9

Effects of a novel lanosterol 14 alpha-demethylase inhibitor on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in Hep G2 cells.

Mayer RJ, Adams JL, Bossard MJ, Berkhout TA. Mayer RJ, et al. Among authors: berkhout ta. J Biol Chem. 1991 Oct 25;266(30):20070-8. J Biol Chem. 1991. PMID: 1657912 Free article.

10

The effect of (-)-hydroxycitrate on the activity of the low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase levels in the human hepatoma cell line Hep G2.

Berkhout TA, Havekes LM, Pearce NJ, Groot PH. Berkhout TA, et al. Biochem J. 1990 Nov 15;272(1):181-6. doi: 10.1042/bj2720181. Biochem J. 1990. PMID: 2176080 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results